Stephen Baxter
Stock Analyst at Wells Fargo
(2.40)
# 2,450
Out of 4,964 analysts
198
Total ratings
45.24%
Success rate
-1.08%
Average return
Main Sectors:
Stocks Rated by Stephen Baxter
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
MOH Molina Healthcare | Maintains: Overweight | $216 → $198 | $174.72 | +13.32% | 19 | Aug 15, 2025 | |
ELV Elevance Health | Maintains: Overweight | $400 → $330 | $310.41 | +6.31% | 12 | Aug 15, 2025 | |
HUM Humana | Maintains: Overweight | $348 → $344 | $297.89 | +15.48% | 11 | Aug 14, 2025 | |
CI The Cigna Group | Maintains: Equal-Weight | $341 → $340 | $299.00 | +13.71% | 8 | Aug 14, 2025 | |
UHS Universal Health Services | Maintains: Overweight | $225 → $210 | $181.22 | +15.88% | 14 | Aug 14, 2025 | |
PNTG The Pennant Group | Maintains: Equal-Weight | $31 → $29 | $24.29 | +19.39% | 2 | Aug 14, 2025 | |
THC Tenet Healthcare | Maintains: Overweight | $195 → $200 | $184.53 | +8.38% | 14 | Aug 14, 2025 | |
HCA HCA Healthcare | Maintains: Equal-Weight | $385 → $375 | $407.28 | -7.93% | 15 | Aug 14, 2025 | |
CYH Community Health Systems | Maintains: Underweight | $3.5 → $2.5 | $2.80 | -10.71% | 10 | Aug 14, 2025 | |
MCK McKesson | Maintains: Equal-Weight | $766 → $772 | $681.02 | +13.36% | 7 | Aug 13, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $337 → $354 | $289.89 | +22.12% | 4 | Aug 13, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $183 → $185 | $149.51 | +23.74% | 8 | Aug 13, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $306 → $267 | $302.29 | -11.67% | 13 | Aug 4, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $72 → $30 | $28.38 | +5.71% | 22 | Jul 23, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $16 → $10 | $17.24 | -42.00% | 11 | Jul 11, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $25 → $27 | $23.73 | +13.78% | 4 | May 13, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $6 → $5 | $1.27 | +293.70% | 7 | May 13, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $76 → $84 | $72.14 | +16.44% | 14 | May 6, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $17 → $15 | $7.89 | +90.11% | 3 | Apr 29, 2024 |
Molina Healthcare
Aug 15, 2025
Maintains: Overweight
Price Target: $216 → $198
Current: $174.72
Upside: +13.32%
Elevance Health
Aug 15, 2025
Maintains: Overweight
Price Target: $400 → $330
Current: $310.41
Upside: +6.31%
Humana
Aug 14, 2025
Maintains: Overweight
Price Target: $348 → $344
Current: $297.89
Upside: +15.48%
The Cigna Group
Aug 14, 2025
Maintains: Equal-Weight
Price Target: $341 → $340
Current: $299.00
Upside: +13.71%
Universal Health Services
Aug 14, 2025
Maintains: Overweight
Price Target: $225 → $210
Current: $181.22
Upside: +15.88%
The Pennant Group
Aug 14, 2025
Maintains: Equal-Weight
Price Target: $31 → $29
Current: $24.29
Upside: +19.39%
Tenet Healthcare
Aug 14, 2025
Maintains: Overweight
Price Target: $195 → $200
Current: $184.53
Upside: +8.38%
HCA Healthcare
Aug 14, 2025
Maintains: Equal-Weight
Price Target: $385 → $375
Current: $407.28
Upside: -7.93%
Community Health Systems
Aug 14, 2025
Maintains: Underweight
Price Target: $3.5 → $2.5
Current: $2.80
Upside: -10.71%
McKesson
Aug 13, 2025
Maintains: Equal-Weight
Price Target: $766 → $772
Current: $681.02
Upside: +13.36%
Aug 13, 2025
Maintains: Overweight
Price Target: $337 → $354
Current: $289.89
Upside: +22.12%
Aug 13, 2025
Maintains: Overweight
Price Target: $183 → $185
Current: $149.51
Upside: +23.74%
Aug 4, 2025
Maintains: Overweight
Price Target: $306 → $267
Current: $302.29
Upside: -11.67%
Jul 23, 2025
Downgrades: Equal-Weight
Price Target: $72 → $30
Current: $28.38
Upside: +5.71%
Jul 11, 2025
Downgrades: Underweight
Price Target: $16 → $10
Current: $17.24
Upside: -42.00%
May 13, 2025
Maintains: Overweight
Price Target: $25 → $27
Current: $23.73
Upside: +13.78%
May 13, 2025
Maintains: Overweight
Price Target: $6 → $5
Current: $1.27
Upside: +293.70%
May 6, 2025
Maintains: Overweight
Price Target: $76 → $84
Current: $72.14
Upside: +16.44%
Apr 29, 2024
Maintains: Equal-Weight
Price Target: $17 → $15
Current: $7.89
Upside: +90.11%